NYSE:ACH
Accendra Health Inc.
Accendra Health Inc.'s revenue grew 3.1% in fiscal 2025 to $2.8B while operating margin rose to 1.0%. Free cash flow was −$292.7M, −10.6% of revenue.Summary generated from Accendra Health Inc.'s SEC filings. Latest annual report filed Feb 20, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$2.8B
Revenue growth+3.1%
Revenue, 5-yr CAGR−20.1%
Gross margin46.7%
Operating margin1.0%
Net margin−39.8%
ROIC1.3%
Return on equity−1755.6%
Debt / equityn/a
Free cash flow−$292.7M
FCF margin−10.6%
Share count change+0.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 9,785 | 9,955 | 2,553 | 2,680 | 2,762 |
| Operating income | 368 | 143 | 133 | −218 | 27 |
| Net income | 222 | 22 | −41 | −363 | −1,101 |
| Free cash flow | 83 | 167 | 568 | −9 | −293 |
Recent filings
- 8-KNotice of delisting or listing-rule failure
Oct 9, 2026 - 4Insider transaction report
Oct 6, 2026 - 8-K/AAmended director or officer change
Sep 28, 2026 - 4Insider transaction report
Sep 24, 2026 - 8-KDirector or officer change
Sep 17, 2026 - 8-KRegulation FD disclosure
Aug 17, 2026 - 8-KEntry into a material agreement
Aug 10, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 10, 2026